London · Delayed Price · Currency is GBP · Price in USD QuidelOrtho Statistics
Total Valuation
QuidelOrtho has a market cap or net worth of GBP 1.18 billion. The enterprise value is 3.12 billion.
| Market Cap | 1.18B |
| Enterprise Value | 3.12B |
Important Dates
The last earnings date was Wednesday, February 11, 2026.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 67.26M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.89% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.00% |
| Owned by Institutions (%) | 116.34% |
| Float | 62.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 10.86 |
| PS Ratio | 0.58 |
| PB Ratio | 0.83 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 15.17 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.71 |
| EV / Sales | 1.56 |
| EV / EBITDA | 7.72 |
| EV / EBIT | 77.50 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.50, with a Debt / Equity ratio of 1.46.
| Current Ratio | 1.50 |
| Quick Ratio | 0.61 |
| Debt / Equity | 1.46 |
| Debt / EBITDA | 5.10 |
| Debt / FCF | n/a |
| Interest Coverage | 0.31 |
Financial Efficiency
Return on equity (ROE) is -46.15% and return on invested capital (ROIC) is 1.17%.
| Return on Equity (ROE) | -46.15% |
| Return on Assets (ROA) | 0.56% |
| Return on Invested Capital (ROIC) | 1.17% |
| Return on Capital Employed (ROCE) | 1.14% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 306,750 |
| Profits Per Employee | -127,163 |
| Employee Count | 6,600 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 2.62 |
Taxes
In the past 12 months, QuidelOrtho has paid 17.87 million in taxes.
| Income Tax | 17.87M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.01% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -38.01% |
| 50-Day Moving Average | 42.22 |
| 200-Day Moving Average | 41.20 |
| Relative Strength Index (RSI) | 49.59 |
| Average Volume (20 Days) | 177 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 10.34 |
Income Statement
In the last 12 months, QuidelOrtho had revenue of GBP 2.02 billion and -839.27 million in losses. Loss per share was -12.38.
| Revenue | 2.02B |
| Gross Profit | 944.87M |
| Operating Income | 40.64M |
| Pretax Income | -821.40M |
| Net Income | -839.27M |
| EBITDA | 368.40M |
| EBIT | 40.64M |
| Loss Per Share | -12.38 |
Balance Sheet
The company has 125.91 million in cash and 2.08 billion in debt, with a net cash position of -1.95 billion.
| Cash & Cash Equivalents | 125.91M |
| Total Debt | 2.08B |
| Net Cash | -1.95B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.42B |
| Book Value Per Share | 20.94 |
| Working Capital | 356.83M |
Cash Flow
| Operating Cash Flow | 78.01M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 46.67%, with operating and profit margins of 2.01% and -41.45%.
| Gross Margin | 46.67% |
| Operating Margin | 2.01% |
| Pretax Margin | -40.57% |
| Profit Margin | -41.45% |
| EBITDA Margin | 18.20% |
| EBIT Margin | 2.01% |
| FCF Margin | n/a |
Dividends & Yields
QuidelOrtho does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.89% |
| Shareholder Yield | -0.89% |
| Earnings Yield | -70.91% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |